Background. Isavuconazole (ISA) is a once-daily, extended-spectrum triazole approved for treatment of invasive aspergillosis and mucormycosis. The pharmacokinetic profile, daily dosing, lack of therapeutic drug monitoring (TDM) and reduced cost make ISA a promising option for use as prophylaxis for invasive fungal infections (IFIs). We report our experience with use of ISA for prophylaxis of IF...

This study is a part of an ongoing ISA project in Denmark. Its aim was to clarify two human factors issues, (1) the difference in attitude between ISA-volunteers and non-volunteers, and (2) the relative impact on speeding of two factors, ISA-information and driver motivation. The first part of the study compared survey data from ISA-volunteers with those of non-volunteers. The two groups differ...

We introduce and study the partial singular braid monoid PSBn, a monoid that contains both the inverse braid monoid IBn and the singular braid monoid SBn. Our main results include a characterization of Green’s relations, a presentation in terms of generators and relations, and a proof that PSBn embeds in the semigroup algebra C[IBn].

bark". Dietrich provides eleven notes to Ibn al-Baitar's commentary and, as he does in all entries, attempts to identify the plant in modern nomenclature. In this instance, however, Dietrich says, "The plant's identification is very doubtful, perhaps impossible to know". And, he references his discussion of the plant in his Dioscurides triumphans. The reverse happens as well. As an illustration...

Background. Isavuconazole (ISA) is a once-daily, extended-spectrum triazole approved for treatment of invasive aspergillosis and mucormycosis. The pharmacokinetic profile, daily dosing, lack of therapeutic drug monitoring (TDM) and reduced cost make ISA a promising option for use as prophylaxis for invasive fungal infections (IFIs). We report our experience with use of ISA for prophylaxis of IF...

Background. Isavuconazole (ISA) is a once-daily, extended-spectrum triazole approved for treatment of invasive aspergillosis and mucormycosis. The pharmacokinetic profile, daily dosing, lack of therapeutic drug monitoring (TDM) and reduced cost make ISA a promising option for use as prophylaxis for invasive fungal infections (IFIs). We report our experience with use of ISA for prophylaxis of IF...

This section 9.3 of Ibn Sı̄nā’s Qiyās is a commentary on sections 25 and 26 of Aristotle’s Prior Analytics i, pages 41b36–43a19. NB the parallel passage in Ibn Sı̄nā’s Burhān iii.2, p. 136ff (Badawi). The paper below is what Wikipedia would call a stub. I will add and correct as time allows. I make the paper available now because it contains a complete translation of Qiyās section 9.3, which is a...